Latest Commercialization News

Zinc of Ireland NL has applied for a new exploration licence in Western Australia's Murchison region, signaling a strategic pivot towards gold while refining its zinc and lead assets in Ireland and exiting Canadian holdings.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Mantle Minerals reports encouraging drilling results confirming Hemi-style gold mineralisation at Mount Berghaus and Roberts Hill, setting the stage for expanded exploration in 2025.

Industrial Minerals Ltd reports encouraging progress in its High Purity Quartz projects, including promising testwork results and strategic marketing efforts in China, supported by a recent $2.3 million capital raise.

Kore Potash has signed a landmark $1.929 billion fixed-price EPC contract for its Kola Potash Project, reinforcing its strategy to become a low-cost producer. The company is now awaiting a financing proposal from the Summit Consortium expected by February 2025.

Atlantic Lithium has cleared critical regulatory hurdles for its Ewoyaa Lithium Project in Ghana, securing key permits and raising A$10 million to advance construction plans. The company also updated its feldspar resource estimate, underscoring the project's growing commercial potential.

Green Critical Minerals has made significant strides in commercialising its Very High-Density (VHD) Graphite technology, achieving exceptional pilot plant results and positioning itself at the forefront of clean energy and electronics markets.

EcoGraf Limited advances its vertically integrated battery anode materials business with a significant UFK loan mandate and progress across upstream, midstream, and downstream operations.

Critica Limited reports exceptional progress at its Jupiter Project, highlighted by record-breaking drilling results and a significant rare earths concentrate upgrade, with a maiden Mineral Resource Estimate due mid-February 2025.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.

Impact Minerals reports a maiden Measured Resource at its Lake Hope High Purity Alumina Project and secures $2.87 million in government funding to accelerate pilot plant development, while progressing exploration and IPO plans for other assets.